Grantham, Mayo, Van Otterloo & Co (GMO)’s Gentex GNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $306K | Sell |
12,095
-16,149
| -57% | -$382K | ﹤0.01% | 603 |
|
|
2026
Q1 | $617K | Sell |
28,244
-21,204
| -43% | -$492K | ﹤0.01% | 546 |
|
|
2025
Q4 | $1.15M | Buy |
49,448
+37,042
| +299% | +$893K | ﹤0.01% | 496 |
|
|
2025
Q3 | $351K | Buy |
+12,406
| New | +$330K | ﹤0.01% | 551 |
|
|
2025
Q2 | – | Sell |
-22,862
| Closed | -$533K | – | 641 |
|
|
2025
Q1 | $533K | Sell |
22,862
-1,214,975
| -98% | -$31.1M | ﹤0.01% | 544 |
|
|
2024
Q4 | $35.6M | Buy |
1,237,837
+47,832
| +4% | +$1.43M | 0.12% | 114 |
|
|
2024
Q3 | $35.3M | Buy |
1,190,005
+128,211
| +12% | +$3.98M | 0.11% | 131 |
|
|
2024
Q2 | $35.8M | Buy |
1,061,794
+73,612
| +7% | +$2.54M | 0.12% | 115 |
|
|
2024
Q1 | $35.7M | Buy |
988,182
+433,392
| +78% | +$15M | 0.13% | 114 |
|
|
2023
Q4 | $18.1M | Sell |
554,790
-39,001
| -7% | -$1.2M | 0.08% | 183 |
|
|
2023
Q3 | $19.3M | Buy |
593,791
+94,200
| +19% | +$3.02M | 0.09% | 184 |
|
|
2023
Q2 | $14.6M | Hold |
499,591
| – | – | 0.07% | 214 |
|
|
2023
Q1 | $14M | Buy |
499,591
+167,335
| +50% | +$4.71M | 0.07% | 214 |
|
|
2022
Q4 | $9.06M | Buy |
332,256
+11,267
| +4% | +$301K | 0.05% | 247 |
|
|
2022
Q3 | $7.65M | Buy |
+320,989
| New | +$8.81M | 0.04% | 268 |
|
|
2021
Q1 | – | Sell |
-30,248
| Closed | -$1.03M | – | 882 |
|
|
2020
Q4 | $1.03M | Sell |
30,248
-13,400
| -31% | -$413K | 0.01% | 562 |
|
|
2020
Q3 | $1.12M | Hold |
43,648
| – | – | 0.01% | 498 |
|
|
2020
Q2 | $1.13M | Buy |
43,648
+100
| +0.2% | +$2.51K | 0.01% | 511 |
|
|
2020
Q1 | $965K | Sell |
43,548
-31,500
| -42% | -$875K | 0.01% | 503 |
|
|
2019
Q4 | $2.17M | Buy |
75,048
+4,400
| +6% | +$124K | 0.01% | 385 |
|
|
2019
Q3 | $1.95M | Buy |
70,648
+15,900
| +29% | +$420K | 0.01% | 438 |
|
|
2019
Q2 | $1.35M | Buy |
+54,748
| New | +$1.24M | 0.01% | 497 |
|
|
2019
Q1 | – | Sell |
-84,200
| Closed | -$1.7M | – | 718 |
|
|
2018
Q4 | $1.7M | Sell |
84,200
-20,800
| -20% | -$436K | 0.01% | 303 |
|
|
2018
Q3 | $2.25M | Buy |
+105,000
| New | +$2.43M | 0.02% | 294 |
|
|
2017
Q3 | – | Sell |
-249,429
| Closed | -$4.73M | – | 589 |
|
|
2017
Q2 | $4.73M | Sell |
249,429
-31,800
| -11% | -$620K | 0.03% | 248 |
|
|
2017
Q1 | $6M | Buy |
281,229
+47,266
| +20% | +$992K | 0.03% | 221 |
|
|
2016
Q4 | $4.61M | Buy |
233,963
+52,787
| +29% | +$961K | 0.02% | 246 |
|
|
2016
Q3 | $3.18M | Sell |
181,176
-221,896
| -55% | -$3.83M | 0.02% | 291 |
|
|
2016
Q2 | $6.23M | Buy |
403,072
+136,791
| +51% | +$2.17M | 0.03% | 276 |
|
|
2016
Q1 | $4.18M | Buy |
266,281
+25,000
| +10% | +$364K | 0.02% | 309 |
|
|
2015
Q4 | $3.86M | Sell |
241,281
-18,100
| -7% | -$292K | 0.01% | 282 |
|
|
2015
Q3 | $4.02M | Sell |
259,381
-10,471
| -4% | -$166K | 0.01% | 263 |
|
|
2015
Q2 | $4.43M | Sell |
269,852
-82,700
| -23% | -$1.45M | 0.01% | 261 |
|
|
2015
Q1 | $6.45M | Sell |
352,552
-13,200
| -4% | -$233K | 0.02% | 237 |
|
|
2014
Q4 | $6.61M | Sell |
365,752
-64,288
| -15% | -$1.07M | 0.02% | 229 |
|
|
2014
Q3 | $5.76M | Sell |
430,040
-26,160
| -6% | -$380K | 0.02% | 256 |
|
|
2014
Q2 | $6.63M | Buy |
456,200
+182,200
| +66% | +$2.66M | 0.02% | 228 |
|
|
2014
Q1 | $4.32M | Buy |
+274,000
| New | +$4.37M | 0.01% | 318 |
|
Other funds holding GNTX
AI
Grantham, Mayo, Van Otterloo & Co (GMO)'s GNTX Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Gentex (GNTX) stake by 57% in Q2 2026, selling an estimated $382K and leaving 12,095 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #603.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GNTX in Q1 2014 and has held it in 38 quarters since. The position peaked at $35.8M in Q2 2024. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 12,095 shares of Gentex worth $306K as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 16,149 Gentex shares in Q2 2026, an estimated $382K.
- Gentex made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #603 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gentex in Q1 2014 and has held it in 38 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Gentex position peaked at $35.8M in Q2 2024.
- 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.